Across TCGA pan-cancer cohorts, RNU6-294P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-294P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-294P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-294P expression acts as an unfavorable survival marker.

BLCA and STAD are the cancer types where RNU6-294P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.161	0.627	<.001	54	view →
STAD	DFS	Tertile	All	0.224	0.713	.001	27	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-294P tumor-vs-normal RNA expression · all RNU6-294P data types